Risedronate sodium 30 MG Oral Tablet — RxCUI 905032
RxNorm drug concept · Semantic clinical drug
RxCUI 905032
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
35 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI905032
Official nameRisedronate sodium 30 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped16
Package NDCs mapped35
Reported Medicaid activity (SDUD)1,654 prescriptions · 5 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Risedronate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Risedronate works by slowing down the cells in your body that break bone down. Normally your bones are constantly being broken down and rebuilt, but in conditions like osteoporosis...
- What exactly does risedronate do for my bones?
- It really does matter — this is one of the most important things to get right. If you're taking the regular tablet, you need to take it first thing in the morning, at least 30 minu...
- Does it matter when I take risedronate, or can I just take it whenever?
🕸️ Concept Web — How Risedronate sodium 30 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Risedronate sodium 30 MG Oral Tablet
RxCUI 905032 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Risedronate
73056IN -
Risedronate sodium
60334PIN
-
Risedronate
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Actonel
753143BN
-
Actonel
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Risedronate Oral Tablet
617278SCDF -
Risedronate sodium Oral Tablet
2648069SCDFP -
Risedronate Oral Product
1165476SCDG -
Risedronate Pill
1165477SCDG -
Risedronate sodium Oral Product
2659877SCDGP -
Risedronate sodium Pill
2661515SCDGP -
Risedronate Oral Tablet [Actonel]
753145SBDF -
Risedronate sodium Oral Tablet [Actonel]
2657670SBDFP - +5 more in this family
-
Risedronate Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Risedronate sodium 30 MG
905031SCDC -
Risedronate sodium 30 MG Oral Tablet [Actonel]
905034SBD -
Risedronate sodium 30 MG [Actonel]
905033SBDC
-
Risedronate sodium 30 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Risedronate sodium 30 MG
SCDC · 905031 -
Risedronate Oral Tablet
SCDF · 617278 -
Risedronate sodium Oral Tablet
SCDFP · 2648069 -
Risedronate Oral Product
SCDG · 1165476 -
Risedronate Pill
SCDG · 1165477 -
Risedronate sodium Oral Product
SCDGP · 2659877 -
Risedronate sodium Pill
SCDGP · 2661515
Brand-Name Concepts
-
Risedronate sodium 30 MG Oral Tablet [Actonel]
SBD · 905034 -
Risedronate sodium 30 MG [Actonel]
SBDC · 905033 -
Risedronate Oral Tablet [Actonel]
SBDF · 753145 -
Risedronate sodium Oral Tablet [Actonel]
SBDFP · 2657670 -
Actonel Oral Product
SBDG · 1169918 -
Actonel Pill
SBDG · 1169919 -
Actonel
BN · 753143
📦 FDA Products & Package NDCs
16 products · 35 package NDCs
35 package NDCs map to RxCUI 905032 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-3098-29 | 12 BLISTER PACK in 1 CARTON (0093-3098-29) / 1 TABLET, FILM... | Risedronate Sodium | Teva Pharmaceuticals USA, Inc. | 2015-06-01 |
| 00093-3098-44 | 4 BLISTER PACK in 1 CARTON (0093-3098-44) / 1 TABLET, FILM... | Risedronate Sodium | Teva Pharmaceuticals USA, Inc. | 2015-06-01 |
| 00093-3099-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-3099-56) | Risedronate Sodium | Teva Pharmaceuticals USA, Inc. | 2015-06-01 |
| 00093-3100-56 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-3100-56) | Risedronate Sodium | Teva Pharmaceuticals USA, Inc. | 2015-06-01 |
| 00430-0472-03 | 4 TABLET, FILM COATED in 1 DOSE PACK (0430-0472-03) | Actonel | Allergan, Inc. | 2002-05-17 |
| 00430-0478-01 | 1 TABLET, FILM COATED in 1 DOSE PACK (0430-0478-01) | Actonel | Allergan, Inc. | 2008-04-22 |
| 33342-0107-06 | 3 BLISTER PACK in 1 CARTON (33342-107-06) / 10 TABLET, FILM... | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 33342-0107-07 | 30 TABLET, FILM COATED in 1 CONTAINER (33342-107-07) | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 33342-0107-49 | 2000 TABLET, FILM COATED in 1 CONTAINER (33342-107-49) | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 33342-0108-06 | 3 BLISTER PACK in 1 CARTON (33342-108-06) / 10 TABLET, FILM... | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 33342-0108-07 | 30 TABLET, FILM COATED in 1 CONTAINER (33342-108-07) | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 33342-0108-15 | 500 TABLET, FILM COATED in 1 CONTAINER (33342-108-15) | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 33342-0109-37 | 1 BLISTER PACK in 1 CARTON (33342-109-37) / 4 TABLET, FILM... | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 33342-0109-50 | 3 BLISTER PACK in 1 CARTON (33342-109-50) / 4 TABLET, FILM... | Risedronate Sodium | Macleods Pharmaceuticals Limited | 2015-12-09 |
| 47335-0666-08 | 100 TABLET, FILM COATED in 1 BOTTLE (47335-666-08) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0666-18 | 1000 TABLET, FILM COATED in 1 BOTTLE (47335-666-18) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0666-83 | 30 TABLET, FILM COATED in 1 BOTTLE (47335-666-83) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0666-88 | 100 TABLET, FILM COATED in 1 BOTTLE (47335-666-88) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0667-08 | 100 TABLET, FILM COATED in 1 BOTTLE (47335-667-08) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0667-18 | 1000 TABLET, FILM COATED in 1 BOTTLE (47335-667-18) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0667-83 | 30 TABLET, FILM COATED in 1 BOTTLE (47335-667-83) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0667-88 | 100 TABLET, FILM COATED in 1 BOTTLE (47335-667-88) | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0668-62 | 3 BLISTER PACK in 1 CARTON (47335-668-62) / 4 TABLET, FILM... | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0668-68 | 1 BLISTER PACK in 1 CARTON (47335-668-68) / 4 TABLET, FILM... | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2015-11-30 |
| 47335-0727-98 | 1 BLISTER PACK in 1 CARTON (47335-727-98) / 2 TABLET, FILM... | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2014-06-11 |
| 47335-0928-60 | 1 BLISTER PACK in 1 CARTON (47335-928-60) / 1 TABLET, FILM... | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2014-06-11 |
| 47335-0928-67 | 3 BLISTER PACK in 1 CARTON (47335-928-67) / 1 TABLET, FILM... | risedronate sodium | Sun Pharmaceutical Industries, Inc. | 2014-06-11 |
| 65862-0517-22 | 2000 TABLET, FILM COATED in 1 BOTTLE (65862-517-22) | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
| 65862-0517-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-517-30) | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
| 65862-0517-78 | 10 BLISTER PACK in 1 CARTON (65862-517-78) / 10 TABLET, FIL... | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
| 65862-0518-30 | 30 TABLET, FILM COATED in 1 BOTTLE (65862-518-30) | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
| 65862-0518-78 | 10 BLISTER PACK in 1 CARTON (65862-518-78) / 10 TABLET, FIL... | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
| 65862-0518-99 | 1000 TABLET, FILM COATED in 1 BOTTLE (65862-518-99) | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
| 65862-0519-04 | 1 BLISTER PACK in 1 CARTON (65862-519-04) / 4 TABLET, FILM... | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
| 65862-0519-08 | 3 BLISTER PACK in 1 CARTON (65862-519-08) / 4 TABLET, FILM... | Risedronate Sodium | Aurobindo Pharma Limited | 2015-11-30 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (13) ·
Aurobindo Pharma Limited (8) ·
Macleods Pharmaceuticals Limited (8) ·
Teva Pharmaceuticals USA, Inc. (4) ·
Allergan, Inc. (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.